+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

  • ID: 4828797
  • Report
  • August 2019
  • Region: Global
  • 104 pages
  • IMARC Group
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Avita Medical
  • Cytori Therapeutics
  • Johnson & Johnson
  • Mallinckrodt
  • Mölnlycke Health Care
  • Nuo Therapeutics
  • MORE
The global wound care biologics market was worth US$ 1.40 Billion in 2018. Wound care biologics refer to drugs extracted or semi-synthesized from natural sources which are used for controlling and healing infections. Wound healing is a complex process involving inflammation, accumulation of fibrous tissue, deposition of collagen, formation of epithelial cell layers and other disruptions. Biologic wound healing treatments possess the ability to restore the natural repair mechanism through active biological agents. For instance, plant-derived active biomolecules with antimicrobial, anti-inflammatory or antioxidant properties have proven efficacious in advancing the wound-healing process. Some of the recent technological advancements made in the field of wound healing include skin substitutes, bio-membranes, scaffolds, hydroconductive dressings and biologics.

Chronic skin wounds can be caused due to burns, skin cancers, infections, trauma or an underlying medical condition such as diabetes. With the growing prevalence of these ailments along with the expanding geriatric population, there has been a rise in the demand for treatments that can accelerate wound healing and facilitate a speedy recovery. Along with this, several initiatives have been undertaken by governments across the globe to create awareness about the benefits of wound care biologics among patients. Apart from this, manufacturers are also developing next-generation, cost-effective and high-quality biologics to make them more accessible. Moreover, many research and healthcare centers are entering into partnerships to modernize wound care treatments and develop innovative drugs for healing wounds. For example, researchers are focusing on integrating antimicrobial compounds into the wound dressing itself. These materials combine traditional wound dressings such as hydrogels or foams with antimicrobial compounds such as betaine, silver, chitin, or polyhexamethylene biguanide. Looking forward, The publisher expects the market to reach a value of US$ 2.35 Billion by 2024, registering a CAGR of around 9% during 2019-2024.

Report Coverage:

Historical, Current and Future Market Trends

Market Breakup by Product:
Biologic Skin Substitutes
Human Donor Tissue -Derived Products
Acellular Animal -Derived Products
Biosynthetic Products
Topical Agents

Market Breakup by Wound Type:
Ulcers
Diabetic Foot Ulcers
Venous Ulcers
Pressure Ulcers
Others
Surgical and Traumatic Wounds
Burns

Market Breakup by Application:
Acute Wound
Chronic Wound
Surgical Wound

Market Breakup by End-User:
Hospitals
ASCs
Burn Centres and Wound Clinics

Market Breakup by Region:
Asia Pacific
Europe
North America
Middle East and Africa
Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Smith & Nephew, Mölnlycke Health Care, Integra lifesciences, Osiris Therapeutics, Avita Medical, ConvaTec Group, Cytori Therapeutics, Mylan, Johnson & Johnson, Leap Therapeutics, Nuo Therapeutics, Mallinckrodt, Wright Medical, Mimedx Group, Solsys Medical, etc.

Key Questions Answered in This Report:

How has the global wound care biologics market performed so far and how will it perform in the coming years?
What are the key regional markets in the global wound care biologics industry?
What is the breakup of the market based on the product?
What is the breakup of the market based on the wound type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the global wound care biologics industry?
What are the key driving factors and challenges in the global wound care biologics industry?
What is the structure of the global wound care biologics industry and who are the key players?
What is the degree of competition in the global wound care biologics industry?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Avita Medical
  • Cytori Therapeutics
  • Johnson & Johnson
  • Mallinckrodt
  • Mölnlycke Health Care
  • Nuo Therapeutics
  • MORE
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Wound Care Biologics Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Product
5.4 Market Breakup by Wound Type
5.5 Market Breakup by Application
5.6 Market Breakup by End-User
5.7 Market Breakup by Region
5.8 Market Forecast

6 Market Breakup by Product
6.1 Biologic Skin Substitutes
6.1.1 Market Trends
6.1.2 Market Breakup by Type
6.1.2.1 Human Donor Tissue-Derived Products
6.1.2.2 Acellular Animal-Derived Products
6.1.2.3 Biosynthetic Products
6.1.3 Market Forecast
6.2 Topical Agents
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Wound Type
7.1 Ulcers
7.1.1 Market Trends
7.1.2 Market Breakup by Type
7.1.2.1 Diabetic Foot Ulcers
7.1.2.2 Venous Ulcers
7.1.2.3 Pressure Ulcers
7.1.2.4 Others
7.1.3 Market Forecast
7.2 Surgical and Traumatic Wounds
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Burns
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Application
8.1 Acute Wound
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Chronic Wound
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Surgical Wound
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by End-User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 ASCs
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Burn Centres and Wound Clinics
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region
10.1 Asia Pacific
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 North America
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast

11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porter’s Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Smith & Nephew
15.3.2 Mölnlycke Health Care
15.3.3 Integra lifesciences
15.3.4 Osiris Therapeutics
15.3.5 Avita Medical
15.3.6 ConvaTec Group
15.3.7 Cytori Therapeutics
15.3.8 Mylan
15.3.9 Johnson & Johnson
15.3.10 Leap Therapeutics
15.3.11 Nuo Therapeutics
15.3.12 Mallinckrodt
15.3.13 Wright Medical
15.3.14 Mimedx Group
15.3.15 Solsys Medical
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Smith & Nephew
  • Mölnlycke Health Care
  • Integra lifesciences
  • Osiris Therapeutics
  • Avita Medical
  • ConvaTec Group
  • Cytori Therapeutics
  • Mylan
  • Johnson & Johnson
  • Leap Therapeutics
  • Nuo Therapeutics
  • Mallinckrodt
  • Wright Medical
  • Mimedx Group
  • Solsys Medical
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll